By WSJ Staff
Novo Nordisk (NVO): The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease. Shares climbed roughly 4.5% in Denmark (read more about weight-loss drugs' surprise foe).
Soho House $(SHCO)$: Investors led by one of the U.S.'s biggest hotel owners are nearing a deal to take Soho House private, The Wall Street Journal reported. Shares in the members' club operator rose 13% in premarket trading.
UnitedHealth $(UNH)$: Shares gained 3% premarket, after leaping Friday following Berkshire Hathaway $(BRK.B)$'s disclosure that it had taken a stake in the embattled health insurer.
Grand Canyon Education $(LOPE)$: The Federal Trade Commission dismissed a Biden-era complaint that accused the education company of falsely claiming to be a nonprofit.
Palo Alto Networks (PANW): The cybersecurity company is set to publish quarterly results after the market close. It recently agreed to buy CyberArk Software $(CYBR)$ for $25 billion.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
August 18, 2025 05:23 ET (09:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。